Expanding the use of abiraterone in prostate cancer: Is earlier always better?

Keith T. Schmidt, Ravi A. Madan, William D. Figg*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Expanding the use of abiraterone in prostate cancer: Is earlier always better?'. Together they form a unique fingerprint.

Medicine & Life Sciences